Effects of Celecoxib on Cycle Kinetics of Gastric Cancer Cells and Protein Expression of Cytochrome C and Caspase-9 |
Wang, Yu-Jie
(Department of Gastroenterology, Zhengzhou People's Hospital Affiliated to Southern Medical University)
Niu, Xiao-Ping (Department of Digestion Medicine, Yijishan Hospital of Wannan Medicine College) Yang, Li (Department of Gastroenterology, Zhengzhou People's Hospital Affiliated to Southern Medical University) Han, Zhen (Department of Digestion Medicine, Yijishan Hospital of Wannan Medicine College) Ma, Ying-Jie (Department of Gastroenterology, Zhengzhou People's Hospital Affiliated to Southern Medical University) |
1 | Ogunwobi OO, Liu C (2011). Hepatocyte growth factor upregulation promotes carcinogenesis and epithelialmesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis, 28, 721-31. DOI |
2 | Ohno Y, Ohno S, Suzuki N, et al (2005). Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma. Int J Cancer, 114, 696-701. DOI ScienceOn |
3 | Park SW, Kim HS, Hah JW, et al (2010). Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines. Anticancer Drugs, 21, 823-30. DOI ScienceOn |
4 | Pietenpol JA, Stewart ZA (2002). Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology, 181-182, 475-81. DOI ScienceOn |
5 | Smith WL, DeWitt DL, Garavito RM (2000). Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem, 69, 145-82. DOI ScienceOn |
6 | Sobolewski C, Cerella C, Dicato M, Diederich M (2011). Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells. Cell Cycle, 10, 2978-93. DOI |
7 | Thiel A, Mrena J, Ristimaki A (2011). Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev, 30, 387-95. DOI ScienceOn |
8 | Wang GY, Zhang JW, Lu QH, Xu RZ, Dong QH (2007). Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation. J Zhejiang Univ Sci B, 8, 248-55. DOI ScienceOn |
9 | Wu K, Nie Y, Guo C, et al (2009). Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol, 24, 37-41. DOI ScienceOn |
10 | Xiao H, Zhang Q, Lin Y, Reddy BS, Yang CS (2008). Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer, 122, 2115-24. DOI ScienceOn |
11 | Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T (2004). Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome. J Asian Nat Prod Res, 6, 127-38. DOI ScienceOn |
12 | Arber N (2008). Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point. Cancer Epidemiol Biomarkers Prev, 17, 1852-7. DOI ScienceOn |
13 | Barr H (2011). Gastrointestinal cancer: current screening strategies. Recent Results Cancer Res, 185, 149-57. DOI |
14 | Bazuro GE, Torino F, Gasparini G, Capurso L (2008). Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? Minerva Gastroenterol Dietol, 54, 429-44. |
15 | Calviello G, Di Nicuolo F, Piccioni E, et al (2003). gamma-Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release. Carcinogenesis, 24, 427-33. DOI ScienceOn |
16 | Chakraborti AK, Garg SK, Kumar R, Motiwala HF, Jadhavar PS (2010). Progress in COX-2 inhibitors: a journey so far. Curr Med Chem, 17, 1563-93. DOI ScienceOn |
17 | Chen WT, Hung WC, Kang WY, et al (2009). Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxiainducible factor-1alpha expression, and tumor angiogenesis. APMIS, 117, 176-84. DOI ScienceOn |
18 | Clemett D, Goa KL (2000). Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs, 59, 957-80. DOI ScienceOn |
19 | Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7. DOI ScienceOn |
20 | Entezari Heravi R, Hadizadeh F, Sankian M, et al (2011). Novel selective Cox-2 inhibitors induce apoptosis in Caco-2 colorectal carcinoma cell line. Eur J Pharm Sci, 44, 479-86. DOI ScienceOn |
21 | Fischer SM, Hawk ET, Lubet RA (2011). Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res, 4, 1728-35. DOI ScienceOn |
22 | Fisher JC, Gander JW, Haley MJ, et al (2011). Inhibition of cyclooxygenase 2 reduces tumor metastasis and inflammatory signaling during blockade of vascular endothelial growth factor. Vasc Cell, 3, 22. DOI ScienceOn |
23 | Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K (2007). Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers. J Gastrointest Cancer, 38, 78-82. DOI ScienceOn |
24 | Ghosh N, Chaki R, Mandal V, Mandal SC (2010). COX-2 as a target for cancer chemotherapy. Pharmacol Rep, 62, 233-44. DOI |
25 | Gu Q, Wang JD, Xia HH, et al (2005). Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer. Carcinogenesis, 26, 541-6. |
26 | Hsu YL, Kuo YC, Kuo PL, et al (2005). Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines. Cancer Lett, 221, 77-89. DOI ScienceOn |
27 | Khan Z, Khan N, Tiwari RP, et al (2011). Biology of Cox-2: an application in cancer therapeutics. Curr Drug Targets, 12, 1082-93. DOI ScienceOn |
28 | Lai MY, Huang JA, Liang ZH, et al (2004). Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res, 10, 8465-71. DOI ScienceOn |
29 | Li S, Tong Q, Zhang W, et al (2008). Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells. Cancer Invest, 26, 333-7. DOI ScienceOn |
30 | Liu H, Xiao J, Yang Y, et al (2011). COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. Microvasc Res, 82, 131-40. DOI ScienceOn |
31 | Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY (2007). A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2, 3-dihydro-1H-indol-7-yl] -isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. J Pharmacol Exp Ther, 323, 398-405. DOI ScienceOn |
32 | Matthias C, Schuster MT, Zieger S, Harreus U (2006). COX-2 inhibitors celecoxib and rofecoxib prevent oxidative DNA fragmentation. Anticancer Res, 26, 2003-7. |
33 | Mehar A, Macanas-Pirard P, Mizokami A, et al (2008). The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents. J Pharmacol Exp Ther, 324, 1181-7. |
![]() |